Clinical Trial Update: A Study to Evaluate the Effect of BMS-955176 on Pharmacokinetics of Dolutegravir and the Effect of Dolutegravir on the Pharmacokinetics of BMS-955176 [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the pharmacokinetic interactions between BMS-955176 and dolutegravir has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• BMS-955176
• Dolutegravir (dolutegravir)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus | Phase 1 | Status: COMPLETED